TP53 and neoplasm: Mutations in the tumour suppressor gene TP53 (tumour protein p53) are the most frequent alterations in ESCC, being present in approximately 45% of the tumours [13] and occur early in the neoplastic progression, since they can be detected also in the normal surrounding oesophageal tissue [14].